Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page
- ChecktodayChange DetectedDifference0.5%
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.6%
- Check50 days agoChange DetectedDifference0.5%
- Check57 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase II study on combining radiosurgery and Nivolumab for treating brain metastases, while adding new identifiers and collaborators.SummaryDifference34%
Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.